How long can a person live with chronic myeloid leukemia?
Sep 13, 2022
Source: Cainiu Health
Dr. Li Man
Introduction
The survival period of patients with chronic myeloid leukemia is influenced by various factors, including disease stage, treatment methods, and individual differences, and therefore cannot be generalized. Individual factors also impact survival duration, such as the patient's age, baseline health status, and presence of comorbidities. Patients who are younger, in better physical condition, and without severe comorbidities generally have better tolerance to treatment.
In general, the survival period of patients with chronic myeloid leukemia (CML) is influenced by various factors, including disease stage, treatment approach, and individual differences, so it cannot be generalized.
In the past, the prognosis for CML patients was poor, with a relatively short survival period. The median survival from diagnosis to accelerated or blast phase was approximately 3–5 years. However, with continuous advances in medical technology—especially the advent of tyrosine kinase inhibitors (TKIs)—patient survival has significantly improved. If diagnosed early during the chronic phase and treated properly with TKI drugs, many patients can achieve long-term survival, with some living nearly as long as the general population. For high-risk patients or those resistant to TKIs, treatments such as hematopoietic stem cell transplantation may be required; successful transplantation also offers the possibility of long-term survival.
Individual differences further influence survival outcomes, including the patient's age, baseline health status, and presence of comorbidities. Younger patients with good physical condition and no severe comorbidities generally tolerate treatment better and tend to have a more favorable prognosis.
